Event Brief
FDA Declines Approval for Autism Drug Amid Controversy
Filed: Mar 11, 2026 at 2:10 PM ET
Summary: FDA approves leucovorin only for a rare genetic condition, contradicting Trump administration's claims for autism treatment.
WHO: FDA
WHAT: Declined to approve leucovorin for autism treatment
WHEN: Mar 10, 2026 at 6:12 PM ET
WHERE: Location not specified
WHY: Insufficient evidence for drug's effectiveness in autism
ℹ️ This event is analyzed using pattern arcs, velocity indicators, and source analysis in our MI Console.
Know more. Read less.
The BriefBrief follows the story, so you don't have to read every article. See what happened, how it changed, and where it came from, all in one place.
Same format. Every time.
See how stories unfold →